# FDA 483 - Milton Hom, OD - September 03, 2021

Source: https://www.keypedia.com/records/483/milton-hom-od/53eef406-c069-4701-81d4-85908bd0318c

> FDA 483 for Milton Hom, OD on September 03, 2021. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Milton Hom, OD
- Inspection Date: 2021-09-03
- Product Type: other
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Milton M. Hom, O.D., Clinical Investigator in Azusa, CA, revealed significant deficiencies in the conduct of a clinical investigation. The firm failed to adhere to the investigational plan by enrolling subjects who met exclusion criteria and exhibited improper documentation of informed consent. Additionally, the inspection found inadequate maintenance of case histories and source documents, indicating a lack of proper record-keeping practices.

## Related Officers

- [CSO](https://www.keypedia.com/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.keypedia.com/companies/milton-hom-od/18a465e9-c126-4417-9612-16f28c7baa42

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6